New potential mechanism for vision loss discovered
December 6th 2022Researchers from the Deutsches Zentrum für Neurodegenerative Erkrankungen and the Center for Regenerative Therapies Dresden at TU Dresden have found that visual cells in the human retina may not simply die in some diseases, but are mechanically transported out of the retina beforehand.
Read More
Retinal cells may have potential to protect themselves from diabetic retinopathy
December 5th 2022According to researchers, cells within retinal blood vessels are endowed with a previously unappreciated ability to acquire resistance against the damaging effects of hyperglycemia in patients with diabetes mellitus.
Read More
New genetic mutation behind childhood glaucoma identified
December 5th 2022Researchers found through DNA sequencing and confirmed in further testing that a genetic mutation in the THBS1 gene led to the development of severe childhood glaucoma. The discovery may improve disease screening and personalize treatments.
Read More
SparingVision’s lead asset SPVN06 clears IND application in US for treatment of retinitis pigmentosa
December 4th 2022SPVN06 is a breakthrough gene therapy approach aimed at stopping or slowing disease progression in patients affected by IRDs and dry age-related macular degeneration (AMD), regardless of their genetic background.
Read More
Patricia Piers, PhD, discusses a career of innovation in ophthalmology, looks to future
December 2nd 2022In a two-decade career as a researcher at Johnson & Johnson Surgical Vision, Piers has been a part of teams at the forefront of a number of innovations in IOLs. She discusses her career and the outlook for research and development in ophthalmology.
Read More
Belite Bio finalizes phase 3 clinical trial plans for advanced dry AMD treatment with LBS-008
November 18th 2022LBS-008 is an orally administered tablet intended as an early intervention to slow disease progression in patients affected with Stargardt disease and dry age-related macular degeneration.
Read More
NeoLight launches ROP risk management software ROPCheck.com for pediatric ophthalmology space
November 17th 2022According to the company, ROP Check builds upon its pediatric retina screening portfolio, adding digital management (schedule, document, bill, and transfer) for treating patients with retinopathy of prematurity.
Read More
Boarding Orbis Flying Eye Hospital: Not your typical flight experience
November 16th 2022When it is not on a mission, the Orbis Flying Eye Hospital MD-10 aircraft often is situated at an airport where the fully accredited teaching facility is put to use as a mobile simulation center to train ophthalmologists from around the world in some of the latest sight-saving techniques.
Read More
AEYE Health gains FDA clearance to screen diabetics to head off blindness
November 15th 2022The screening of diabetics for retinopathy has recently become reimbursable in the US, the company noted in its news release, and the approval comes after positive Phase 3 clinical trial earlier this year.
Read More